143 related articles for article (PubMed ID: 35102488)
21. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway.
He Y; Jiang X; Duan L; Xiong Q; Yuan Y; Liu P; Jiang L; Shen Q; Zhao S; Yang C; Chen Y
Mol Cancer; 2021 Dec; 20(1):156. PubMed ID: 34856993
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
Guo D; Wang Y; Ren K; Han X
Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
[TBL] [Abstract][Full Text] [Related]
23. Proliferating cell nuclear antigen promotes cell proliferation and tumorigenesis by up-regulating STAT3 in non-small cell lung cancer.
Wang L; Kong W; Liu B; Zhang X
Biomed Pharmacother; 2018 Aug; 104():595-602. PubMed ID: 29803172
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of MRPL35 promotes cell apoptosis and inhibits cell proliferation in non-small-cell lung cancer.
Zhao C; Chen L; Jin Z; Liu H; Ma C; Zhou H; Xu L; Zhou S; Shi Y; Li W; Chen Y; Dou C; Wang X
BMC Pulm Med; 2023 Dec; 23(1):507. PubMed ID: 38093266
[TBL] [Abstract][Full Text] [Related]
25. LncRNA BRCAT54 inhibits the tumorigenesis of non-small cell lung cancer by binding to RPS9 to transcriptionally regulate JAK-STAT and calcium pathway genes.
Yang W; Qian Y; Gao K; Zheng W; Wu G; He Q; Chen Q; Song Y; Wang L; Wang Y; Gu P; Chen B; Zhai R
Carcinogenesis; 2021 Feb; 42(1):80-92. PubMed ID: 32459848
[TBL] [Abstract][Full Text] [Related]
26. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
27. Inhibition of LDHA suppresses cell proliferation and increases mitochondrial apoptosis via the JNK signaling pathway in cervical cancer cells.
Zhang W; Wang C; Hu X; Lian Y; Ding C; Ming L
Oncol Rep; 2022 Apr; 47(4):. PubMed ID: 35191522
[TBL] [Abstract][Full Text] [Related]
28. Novel long non-coding RNA LBX2-AS1 indicates poor prognosis and promotes cell proliferation and metastasis through Notch signaling in non-small cell lung cancer.
Tang LX; Su SF; Wan Q; He P; Xhang Y; Cheng XM
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7419-7429. PubMed ID: 31539129
[TBL] [Abstract][Full Text] [Related]
29. LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p.
Yu L; Chen D; Song J
Thorac Cancer; 2020 Mar; 11(3):603-611. PubMed ID: 31953899
[TBL] [Abstract][Full Text] [Related]
30. Long Noncoding RNA SNHG6 Promotes Proliferation and Inhibits Apoptosis in Non-small Cell Lung Cancer Cells by Regulating miR-490-3p/RSF1 Axis.
Dong Z; Liu H; Zhao G
Cancer Biother Radiopharm; 2020 Jun; 35(5):351-361. PubMed ID: 32202941
[No Abstract] [Full Text] [Related]
31. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
32. PLCε promotes urinary bladder cancer cells proliferation through STAT3/LDHA pathway‑mediated glycolysis.
Cheng H; Hao Y; Gao Y; He Y; Luo C; Sun W; Yuan M; Wu X
Oncol Rep; 2019 May; 41(5):2844-2854. PubMed ID: 30864733
[TBL] [Abstract][Full Text] [Related]
33. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
Liu MX; Zhou KC; Cao Y
Mol Cancer; 2014 Nov; 13():245. PubMed ID: 25373388
[TBL] [Abstract][Full Text] [Related]
34. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
[TBL] [Abstract][Full Text] [Related]
35. Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2.
Cai F; Zhu Q; Miao Y; Shen S; Su X; Shi Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):59-69. PubMed ID: 27629878
[TBL] [Abstract][Full Text] [Related]
36. Reciprocal regulation of c-Src and STAT3 in non-small cell lung cancer.
Byers LA; Sen B; Saigal B; Diao L; Wang J; Nanjundan M; Cascone T; Mills GB; Heymach JV; Johnson FM
Clin Cancer Res; 2009 Nov; 15(22):6852-61. PubMed ID: 19861436
[TBL] [Abstract][Full Text] [Related]
37. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
38. PHB2 promotes tumorigenesis
Wu B; Chang N; Xi H; Xiong J; Zhou Y; Wu Y; Wu S; Wang N; Yi H; Song Y; Chen L; Zhang J
Theranostics; 2021; 11(7):3150-3166. PubMed ID: 33537079
[No Abstract] [Full Text] [Related]
39. Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer.
Zhang J; Sun B; Ruan X; Hou X; Zhi J; Meng X; Zheng X; Gao M
Cancer Biol Med; 2021 Feb; 18(1):105-119. PubMed ID: 33628588
[TBL] [Abstract][Full Text] [Related]
40. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
Huang Y; Ni R; Wang J; Liu Y
Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]